ClearPoint Neuro (NASDAQ:CLPT) versus Milestone Scientific (NYSE:MLSS) Head-To-Head Survey

Milestone Scientific (NYSE:MLSS) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk.

Earnings and Valuation

This table compares Milestone Scientific and ClearPoint Neuro”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$9.42 million	3.95	-$6.93 million	($0.04)	-10.27
ClearPoint Neuro	$36.97 million	12.23	-$25.54 million	($1.18)	-12.57

Milestone Scientific has higher earnings, but lower revenue than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by company insiders. Comparatively, 6.9% of ClearPoint Neuro shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Milestone Scientific and ClearPoint Neuro, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0	0	1	0	3.00
ClearPoint Neuro	1	0	2	0	2.33

Milestone Scientific presently has a consensus target price of $1.00, indicating a potential upside of 143.49%. ClearPoint Neuro has a consensus target price of $25.67, indicating a potential upside of 73.07%. Given Milestone Scientific’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Milestone Scientific is more favorable than ClearPoint Neuro.

Profitability

This table compares Milestone Scientific and ClearPoint Neuro’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
ClearPoint Neuro	-81.76%	-188.09%	-40.88%

Risk & Volatility

Milestone Scientific has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.

Summary

Milestone Scientific beats ClearPoint Neuro on 9 of the 14 factors compared between the two stocks.

About Milestone Scientific

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

About ClearPoint Neuro

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.